Correlation of neurosurgical subspecialization with outcomes in children with malignant brain tumors

被引:104
作者
Albright, AL
Sposto, R
Holmes, E
Zeltzer, PM
Finlay, JL
Wisoff, JH
Berger, MS
Packer, RJ
Pollack, IF
机构
[1] Childrens Canc Grp, Dept Biostat, Arcadia, CA 91066 USA
[2] Childrens Hosp Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA
[3] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA
[4] NYU, Dept Hematol Oncol, New York, NY USA
[5] NYU, Dept Neurosurg, New York, NY 10016 USA
[6] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA
[7] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA
关键词
brain tumor; glioma; malignant astrocytoma; medulloblastoma; outcomes; primitive neuroectodermal tumor;
D O I
10.1097/00006123-200010000-00018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: This study was performed to evaluate the association between the type of neurosurgeon (general or pediatric) and either the extent of tumor removal or the frequency of complications in children undergoing malignant brain tumor resections. METHODS: Data were analyzed from three recent Children's Cancer Group studies: two on medulloblastomas/primitive neuroectodermal tumors and one on malignant gliomas. Neurosurgeons were classified as general neurosurgeons, as designated pediatric neurosurgeons in their institutions, or as members of the American Society of Pediatric Neurosurgeons (ASPN), which requires pediatric neurosurgical experience and practice standards. RESULTS: Data forms from 732 children were analyzed; 485 were from children with medulloblastomas/primitive neuroectodermal tumors, and 247 were from children with malignant gliomas. Operations were performed by 269 neurosurgeons, including 213 general neurosurgeons, 29 designated pediatric neurosurgeons, and 27 ASPN members. The mean number of operations per surgeon was 1.8, 4.9, and 7.6 for general neurosurgeons, designated pediatric neurosurgeons, and ASPN members, respectively. There was a significant relationship between the extent of tumor resection or the amount of residual tumor and the type of neurosurgeon. Designated pediatric neurosurgeons and ASPN members were more likely to remove more than 90% of the tumor and to leave less than 1.5 cc of residual tumor than were general neurosurgeons (P < 0.05). In these studies, the probability of extensive tumor removal correlated with the number of operations the neurosurgeon performed (P < 0.01). Neurological complications occurred in the following proportion of cases: general neurosurgeons, 23%; designated pediatric neurosurgeons, 32%; and ASPN members, 18%. CONCLUSION: Pediatric neurosurgeons are more likely than general neurosurgeons to extensively remove malignant pediatric brain tumors. In these tumors, extent of removal has been demonstrated to influence survival.
引用
收藏
页码:879 / 885
页数:7
相关论文
共 17 条
[1]   Outcome data and analysis in pediatric neurosurgery [J].
Albright, AL ;
Pollack, IF ;
Adelson, PD ;
Solot, JJ .
NEUROSURGERY, 1999, 45 (01) :101-106
[2]   Effects of medulloblastoma resections on outcome in children: A report from the children's cancer group [J].
Albright, AL ;
Wisoff, JH ;
Zeltzer, PM ;
Boyett, JM ;
Rorke, LB ;
Stanley, P .
NEUROSURGERY, 1996, 38 (02) :265-270
[3]  
ALBRIGHT AL, 1989, PEDIATR NEUROSCI, V15, P276
[4]  
CARLIN BP, 1996, BAYES EMPIRICAL BAYE, P80
[5]   Indications, outcomes, and provider volumes for carotid endarterectomy [J].
Cebul, RD ;
Snow, RJ ;
Pine, R ;
Hertzer, NR ;
Norris, DG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (16) :1282-1287
[6]   THE SURGICAL AND NATURAL MORBIDITY OF AGGRESSIVE RESECTION FOR POSTERIOR-FOSSA TUMORS IN CHILDHOOD [J].
COCHRANE, DD ;
GUSTAVSSON, B ;
POSKITT, KP ;
STEINBOK, P ;
KESTLE, JRW .
PEDIATRIC NEUROSURGERY, 1994, 20 (01) :19-29
[7]   COMMON SOLID TUMORS OF CHILDHOOD [J].
CRIST, WM ;
KUN, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (07) :461-471
[8]   Results of a prospective randomized trial comparing standard dose neuraxis irradiation (3,600cGy/2O) with reduced neuraxis irradiation (2,340cGy/13) in patients with low-stage medulloblastoma - A combined Children's Cancer Group Pediatric Oncology Group Study [J].
Deutsch, M ;
Thomas, PRM ;
Krischer, J ;
Boyett, JM ;
Albright, L ;
Aronin, P ;
Langston, J ;
Allen, JC ;
Packer, RJ ;
Linggood, R ;
Mulhern, R ;
Stanley, P ;
Stehbens, JA ;
Duffner, P ;
Kun, L ;
Rorke, L ;
Cherlow, J ;
Freidman, H ;
Finlay, JL ;
Vietti, T .
PEDIATRIC NEUROSURGERY, 1996, 24 (04) :167-176
[9]   POSTOPERATIVE CHEMOTHERAPY AND DELAYED RADIATION IN CHILDREN LESS-THAN 3 YEARS OF AGE WITH MALIGNANT BRAIN-TUMORS [J].
DUFFNER, PK ;
HOROWITZ, ME ;
KRISCHER, JP ;
FRIEDMAN, HS ;
BURGER, PC ;
COHEN, ME ;
SANFORD, RA ;
MULHERN, RK ;
JAMES, HE ;
FREEMAN, CR ;
SEIDEL, FG ;
KUN, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (24) :1725-1731
[10]   RANDOMIZED PHASE-III TRIAL IN CHILDHOOD HIGH-GRADE ASTROCYTOMA COMPARING VINCRISTINE, LOMUSTINE, AND PREDNISONE WITH THE 8-DRUGS-IN-1-DAY REGIMEN [J].
FINLAY, JL ;
BOYETT, JM ;
YATES, AJ ;
WISOFF, JH ;
MILSTEIN, JM ;
GEYER, JR ;
BERTOLONE, SJ ;
MCGUIRE, P ;
CHERLOW, JM ;
TEFFT, M ;
TURSKI, PA ;
WARA, WM ;
EDWARDS, M ;
SUTTON, LN ;
BERGER, MS ;
EPSTEIN, F ;
AYERS, G ;
ALLEN, JC ;
PACKER, RJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :112-123